Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#46–Chris Masterjohn, Ph.D.: Pathways to health and disease (NAD, sirtuins, methylation, choline...

Full title: #46 – Chris Masterjohn, Ph.D.: Navigating the many pathways to health and disease – NAD and sirtuins, methylation, MTHFR and COMT, choline deficiency and NAFLD, TMAO, creatine and more Original release date: 3/25/19 In this episode, Chris Masterjohn, entrepreneur, independent researcher and doctorate in nutrition, elucidates the latest research on the risk and benefits of NAD supplements, and shares his personal intuition on the topic. We also dive deep into choline deficiency and its role in the rising prevalence of nonalcoholic fatty liver disease. From there, Chris enlightens us on the importance of methylation, a simple yet profoundly important biochemical process affecting our physical and mental health. He also describes the variations of the genes MTHFR and COMT, enzymes which play important roles in methylation and which have profound impacts on our well-being. We discuss: -Chris’s background, falling in love with biochemistry, and decision to pursue research over medicine [7:45]; -Choline: what it is, why it is important, and how a deficiency can cause non-alcoholic fatty liver disease [11:45]; -NAFLD: increasing prevalence and potential causes [25:00]; -TMAO: Should we be worried about the TMAO content in choline and our foods? [39:15]; -Types of fatty acids: How they may predispose us to different types of illnesses [53:30]; -Why don’t we see low VLDL in patients with NAFLD? [59:45]; -Understanding flux, and how machine learning may affect medicine in the near future [1:03:15]; -NAD: How it works, supplements, sirtuins, and the central role of the liver [1:09:30]; -Intravenous NAD [1:33:00]; -Oral NR: Is it the optimal way to get more NAD? [1:38:30]; -What is the possible harm of taking an NAD precursor? [1:47:15]; -The MTHFR gene [1:49:45]; -The methylation pathway [1:58:15]; -The COMT gene [2:04:30]; -Creatine: The uses and benefits and it’s important role in methylation [2:10:15]; -Dietary strategies for MTHFR: choline, creatine, folate and glycine [2:16:45]; -How to mitigate the negative effects of NAD supplements [2:23:45]; -A case study of a person with high homocysteine [2:28:00]; -What is the level of evidence that you need to take an action? [2:32:15]; -Does Chris supplement with NAD precursors? And can it improve symptoms of rosacea? [2:35:45]; -Decision making in the face of inconclusive data, and trying to disentangle the placebo effect [2:39:00]; -What does Chris believe to be true that very few people would agree with him about? [2:43:15]; -How to follow Chris’s work [2:48:45]; and -More. Show notes page: https://peterattiamd.com/chrismasterjohn/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

Peter AttiahostChris Masterjohnguest
Jan 8, 20202h 51mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Masterjohn and Attia Explore Choline, Methylation, MTHFR, COMT, and NAD Precursors

  1. Masterjohn argues choline is essential for exporting triglycerides from the liver via VLDL, so deficiency causes fatty liver in humans on parenteral nutrition and in animals regardless of whether sugar, alcohol or fat is the cause.
  2. He discusses the TMAO scare, putting his belief in the story that eggs and meat harm the heart via TMAO near zero, noting fish carry far more TMAO, and he prefers phosphatidylcholine from food over choline bitartrate.
  3. On methylation, both speakers describe MTHFR and COMT variants as continuous spectrums rather than binary mutations, and Masterjohn explains how low MTHFR activity raises choline needs and how riboflavin, B6 and TMG fit in.
  4. On NAD precursors, Masterjohn explains the liver converts oral NR to circulating nicotinamide, doubts NMN and IV NAD make physiological sense, and warns that high-dose NR may drain methyl groups, while noting human trials so far show no benefit.
  5. The two also discuss how to weigh evidence versus personal risk tolerance, the pitfalls of judging supplements by feel or placebo, and the importance of understanding flux rather than static blood snapshots.

IDEAS WORTH REMEMBERING

5 ideas

Choline deficiency alone can produce fatty liver

Because phosphatidylcholine is needed to build VLDL particles, low choline traps triglycerides in the liver; Masterjohn notes nine of ten people on a choline-free diet developed fatty liver in controlled studies.

Diet changes bundle many variables

Masterjohn points out that cutting fructose also changes protein, choline and micronutrients, so human results like the fructose-reduction study are hard to attribute to one factor, and animal data help make sense of them.

MTHFR and COMT variants lie on a spectrum

Masterjohn says there is no true wild type; activity is spread fairly evenly across the population, and the effect of the genotype depends on nutrient supply such as riboflavin and methyl donors.

Homocysteine response depends on which step is the problem

Masterjohn explains that B6 helps break down homocysteine in the fed state, while recycling in the fasted state relies on folate or choline-derived TMG, which may explain why Attia's patient responded only to TMG.

Oral NR acts mainly through liver-made nicotinamide

Based on the Rabinowitz tracer studies, Masterjohn says tissues outside the liver get NAD from circulating nicotinamide, and NR likely works better than plain nicotinamide because it avoids immediate detoxification in the liver.

WORDS WORTH SAVING

5 quotes

I think that the idea that mistaking a concentration for flux is one of the overwhelming interpretive problems in science and in popular science. In both.

— Chris Masterjohn

We all have MTHFR.

— Chris Masterjohn

if you're gonna tinker, you're gonna tinker a lot more successfully if you have a working model of what's going on than if you don't.

— Chris Masterjohn

You can't understand flux with a snapshot. You have to have the goddamn video, right?

— Peter Attia

I really think we really throw the baby out with the bathwater if we don't look at what's been done by the people who are hardcore conventionals.

— Chris Masterjohn

Choline and fatty liver diseaseTMAO controversyMethylation, MTHFR and homocysteineCOMT and dopamine methylationCreatine and glycine as methyl-related supplementsNR, NMN and NAD metabolismEvidence thresholds and self-experimentation

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.